论文部分内容阅读
目的：观察巴曲止血酶在鼻窦内窥镜手术时止血效果。方法：采用巴曲止血酶于术前３０ｍｉｎ肌肉注射１克氏单位（ＫＵ）与术中静脉滴注（静滴）２ＫＵ共观察５１例，其中男性３３例，女性１８例，年龄为２６±ｓ２１ａ。并与术前只行肌肉注射１ＫＵ的相同病人２０例和不用任何止血药物的相同病人３０例作对照。结果：巴曲止血酶肌注和静滴组的出血量为４８±１０ｍＬ，巴曲止血酶肌注组出血量为７７±２５ｍＬ，对照组出血量为１１１±４０ｍＬ，３组间差异显著（Ｐ＜０．０１）。结论：巴曲止血酶用于鼻窦内窥镜手术的止血效果良好，未发生不良反应。
Objective: To observe the effect of batroxobin on hemostasis during endoscopic sinus surgery. Methods: Fifty-one patients were randomly divided into 1kg KU and 2KU Intravenous infusion (intravenous drip) 30min before operation, including 33 males and 18 females, with a mean age of 26 ± s21a . Twenty patients with the same patient who underwent intramuscular injection of 1 KU before surgery and 30 patients with the same patient without any hemostatic drug were compared. RESULTS: Bleeding volume of intraperitoneal and intravenous infusion of batroxobin was 48 ± 10 mL, bleeding volume of intraperitoneal injection of batroxobin was 77 ± 25 mL, and blood loss of control group was 111 ± 40 mL (P <0.01). CONCLUSION: Bartox blockade is effective for hemostasis in endoscopic sinus surgery. No adverse reactions occurred.